SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-162024
Filing Date
2023-06-07
Accepted
2023-06-07 06:07:00
Documents
16
Period of Report
2023-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d407022d8k.htm   iXBRL 8-K 69406
2 EX-2.1 d407022dex21.htm EX-2.1 490982
3 EX-10.1 d407022dex101.htm EX-10.1 81760
4 EX-10.2 d407022dex102.htm EX-10.2 56992
5 EX-99.1 d407022dex991.htm EX-99.1 27985
  Complete submission text file 0001193125-23-162024.txt   1032312

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA prtk-20230606.xsd EX-101.SCH 2855
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20230606_lab.xml EX-101.LAB 17234
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20230606_pre.xml EX-101.PRE 10815
10 EXTRACTED XBRL INSTANCE DOCUMENT d407022d8k_htm.xml XML 3225
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36066 | Film No.: 23997596
SIC: 2834 Pharmaceutical Preparations